MedCrystalForms

MedCrystal Pharmatech is a specialized Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) focused on solid-state chemistry for the pharmaceutical industry. The company provides comprehensive services including crystal form screening, salt selection, polymorph study, and crystallization process development to optimize the physical properties and stability of drug candidates. By leveraging advanced high-throughput screening technologies and analytical characterization, MedCrystal helps pharmaceutical companies accelerate the transition from drug discovery to clinical development. Their expertise ensures that small molecule drugs have the most suitable solid-state form for formulation and regulatory filing. MedCrystal operates state-of-the-art facilities that support both early-stage research and GMP-compliant manufacturing for clinical trials. The firm serves a global client base, ranging from virtual biotech startups to large multinational pharmaceutical corporations.